Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
31m agoAOI Awarded $20.9M Texas Semiconductor Innovation Fund Grant to Advance Manufacturing in Sugar Land
32m agoMineros S.A. Q1 2026 Results Conference Call to Be Held May 7, 2026
42m agoCN Files Shelf Prospectus Qualifying the Issuance of Debt Securities
49m agoHigh Liner Foods Q1 2026 Earnings Conference Call Scheduled for Thursday, May 14, 2026 at 10:00 A.M. (ET)
50m agoBath & Body Works Appoints Veronique Gabai-Pinsky as Chief Brand & Product Officer

Jw Cayman Therapeutics Co Ltd

About

Jw Cayman Therapeutics Co Ltd (HK:2126) — investor relations, events, news, and company updates on 6ix.

Latest News

Oct 31 2025
JW Therapeutics and Regeneron Expand Strategic Collaboration Agreement to Advance TCR-T Cell Therapy Development and Maximize Global Platform Potential
Jun 5 2025
JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao

Financials

Revenue
HK$283.65 M
Market Cap
HK$911.55 M
EPS
-1.49

Community Chat

Ask AI

6ix6ixAIEvents